shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin

首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin

【24h】

shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin

机译：ShRNA介导的磷酸糖激酶1（PGK1）的抑制增强了胃来源腹膜转移中腹腔化疗的细胞毒性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Phosphoglycerate kinase 1 (PGK1) plays metabolic, kinase and translational roles in Peritoneal metastasis (PM) of gastric origin and is associated with chemoresistance. Silencing PGK1 might potentiate the effect of chemotherapy.

机译：背景：磷酸性激酶1（PGK1）在胃来源的腹膜转移（PM）中起代谢，激酶和平移作用，并与化学化相关。沉默PGK1可能会使化疗的影响提高。

著录项

来源
《European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology》 |2020年第1期|共7页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Phosphoglycerate-kinase 1 (PGK1); Peritoneal metastasis; Gastric cancer; Intraperitoneal chemotherapy; shRNA; Adenoviral vector;

机译：磷酸缩醛 - 激酶1（pGK1）;腹膜转移;胃癌;腹腔化疗;shRNA;腺病毒载体;

相似文献

外文文献
中文文献
专利

1. shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin [J] . European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2020,第4aPta1期

机译：ShRNA介导的磷酸糖激酶1（PGK1）的抑制增强了胃来源腹膜转移中腹腔化疗的细胞毒性
2. Complications and management of an implanted intraperitoneal access port system for intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis [J] . EmotoS., IshigamiH., HidemuraA., Japanese journal of clinical oncology. . 2012,第11期

机译：腹膜内化疗治疗腹膜转移性胃癌的腹腔内植入系统的并发症和处理
3. Complications and Management of an Implanted Intraperitoneal Access Port System for Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Metastasis [J] . Shigenobu Emoto1* Hironori Ishigami2 Akio Hidemura3 Hironori Yamaguchi1 Hiroharu Yamashita1 Joji Kitayama1 and Toshiaki Watanabe1 Japanese Journal of Clinical Oncology . 2012,第11期

机译：腹膜内化疗治疗腹膜转移性胃癌的腹腔通路系统的并发症和处理
4. Prophylaxis and Treatment of Advanced Gastric Cancer with Peritoneal Metastasis with Intraperitoneal(I.P.) Administration of Liposome-Carboplatin(Lipo-CBDCA) and Its Clinical Trial in Peritoneal Carcinomatosis(P.C.). [C] . Mizuno I., Yotsuyanagi T., Ishida M., International Gastric Cancer Congress . 2011

机译：腹膜内（I.P，I.P）对腹膜转移的预防和治疗晚期胃癌（I.P。）脂质体 - 卡铂（Lipo-CBDCA）的施用及其在腹膜癌症中的临床试验（P.C。）。
5. Intraperitoneal Chemotherapy for the Treatment of Malignant Peritoneal Mesothelioma. [D] . Leinwand, Joshua Caleb. 2013

机译：腹膜内化学疗法治疗恶性腹膜间皮瘤。
6. Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis [O] . Jun Kinoshita, Sachio Fushida, Tomoya Tsukada, 2014

机译：腹膜内进入系统感染引起的结肠狭窄：胃癌腹膜转移的腹膜内化疗罕见并发症
7. Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis [O] . Jun Kinoshita, Sachio Fushida, Tomoya Tsukada, 2014

机译：腹膜腔进入系统感染引起的结肠狭窄：胃癌腹膜转移的腹膜内化疗罕见并发症

shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin

摘要

著录项

相似文献

相关主题

期刊订阅